Nataraj Pagadala, founder, president, and CEO of LigronBio, discusses his company's goal of using molecular glues to target traditionally undruggable proteins as a route to new therapies for neurodegenerative diseases.

The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of academic researchers and biotechnology companies, with a focus on genomics.

https://www.bioinformaticscro.com/